Remove FDA Remove Fraud Remove Presentation
article thumbnail

Preventing Genetic Testing Fraud: 5 Actions for Health Plans

Healthcare IT Today

The following is a guest article by Erin Rutzler, Vice President of Fraud, Waste, and Abuse at Cotiviti In Delaware, more than 250 Medicare patients underwent unnecessary genetic testing based on telehealth consultations that often lasted less than two minutes— costing Medicare thousands of dollars per patient. In 2021, a U.S.

Fraud 63
article thumbnail

Pharma Sales Rep Pleads Guilty to Healthcare Fraud and Criminal HIPAA Violations

HIPAA Journal

A pharmaceutical sales rep has pleaded guilty to conspiring to commit healthcare fraud and wrongfully disclosing and obtaining patients’ protected health information in an elaborate healthcare fraud scheme involving criminal HIPAA violations. Alario pleaded guilty to his role in the healthcare fraud scheme earlier this month.

Fraud 63
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials

Hall Render

Food and Drug Administration (“FDA”) released draft guidance regarding the conduct of decentralized clinical trials (“DCTs”) for drugs, biological products and devices. This draft guidance expands on previous FDA recommendations released in the midst of the COVID-19 pandemic.

FDA 40
article thumbnail

Repercussions of Clinical Research Fraud and Misconduct that Healthcare Professionals Need to Know

The Health Law Firm

Unfortunately, many also find themselves defending their reputation after being accused of clinical research fraud or research misconduct. Although accusations of research fraud and misconduct have been present for decades, the number of complaints is on the rise, according to the Food and Drug Administration (FDA).

Fraud 40
article thumbnail

Incorporation by Reference Does Not Create a Material Condition of Payment

Hall Render

Defendant pharmaceutical manufacturers applied for and received approval from the FDA to manufacture Gamunex at a facility converted for that purpose. FDA regulations require current Good Manufacturing Practices [cGMP] to be met or the drug shall be deemed adulterated and prohibited from sale. United States ex rel. at *1 & fn.

FDA 40
article thumbnail

IoT Security Risks – How to Make Sure Your Patients and Your Organization are Safe

Healthcare IT Today

Fred Pinkett, Senior Director, Product Management at Security Innovation Meeting the new FDA requirements for medical device security will take more than just network security, it requires security upgrades in all aspects of systems, including their software. Failure to do so can bring devastating consequences.

Fraud 96
article thumbnail

Digital Health in the Metaverse: Three Legal Considerations

Healthcare Law Blog

These advancements, present challenges and raise novel questions as to how the current healthcare and life sciences legal regime would apply to the metaverse. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Data Privacy and Security. 1, 2021). [2]

FDA 90